4-(2-Chloro-9-methyl-9H-purin-6-yl)morpholine

Catalog No. :
ACUHRP645
CAS No. :
1148003-35-3
Molecular Formula :
C10H12ClN5O
Molecular Weight :
253.69

IUPAC Name:4-(2-chloro-9-methyl-9H-purin-6-yl)morpholine

4-(2-Chloro-9-methyl-9H-purin-6-yl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$500.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Chloro-9-methyl-9H-purin-6-yl)morpholine
IUPAC Name4-(2-chloro-9-methyl-9H-purin-6-yl)morpholine
MDL No.MFCD22581537
Molecular FormulaC10H12ClN5O
Molecular Weight253.69
SMILESCN1C=NC2=C(N3CCOCC3)N=C(Cl)N=C12
InChI KeyBJALAVZIHBUVDW-UHFFFAOYSA-N
Synonym9H-Purine, 2-chloro-9-Methyl-6-(4-Morpholinyl)-;2-Chloro-9-methyl-6-(4-morpholinyl)-9H-purine;4-(2-Chloro-9-Methyl-9H-purin-6-yl)Morpholine;4-(2-Chloro-9-methyl-purin-6-yl)morpholine;2-Chloro-9-methyl-6-morpholino-9H-purine;2-chloro-9-methyl-6-(morpholin-4-yl)-9H-purine
CAS No.1148003-35-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACUHRP645 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACFHWP826 route compound structure diagram
    ACFHWP8264010-81-5 In Stock
  4. Then
  5. ACUHRP645 route product structure diagram
    ACUHRP6451148003-35-3
Inquiry

2. ACUHRP645 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFHWP826 route compound structure diagram
    ACFHWP8264010-81-5 In Stock
  4. Then
  5. ACUHRP645 route product structure diagram
    ACUHRP6451148003-35-3
Inquiry

Comments (0)